AI Verdict
MYGN has stronger fundamentals based on our AI analysis.
MYSZ vs MYGN Fundamental Comparison
| Metric | MYSZ | MYGN |
|---|---|---|
| Revenue | $515,000.0 | $824.5M |
| Net Income | $-2.8M | $-365.9M |
| Net Margin | -552.4% | -44.4% |
| ROE | -39.0% | -99.4% |
| ROA | -24.4% | -51.8% |
| Current Ratio | 2.73x | 2.49x |
| Debt/Equity | 0.11x | 0.33x |
| EPS | $-1.00 | $-3.95 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MYSZ vs MYGN: Frequently Asked Questions
Is MYSZ or MYGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MYGN has stronger fundamentals. MYSZ is rated STRONG SELL (85% confidence) while MYGN is rated STRONG SELL (87% confidence). This is not investment advice.
How does MYSZ compare to MYGN fundamentally?
My Size, Inc. has ROE of -39.0% vs MYRIAD GENETICS INC's -99.4%. Net margins are -552.4% vs -44.4% respectively.
Which stock pays higher dividends, MYSZ or MYGN?
MYSZ has a dividend yield of N/A or no dividend while MYGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MYSZ or MYGN for long term?
For long-term investing, consider that MYSZ has STRONG SELL rating with 85% confidence, while MYGN has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MYSZ vs MYGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MYSZ vs MYGN, the AI consensus favors MYGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.